Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4986-5003
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4986
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4986
Reference (year of publication) | Patient data | Treatment regimen | Outcome | |
Demographics | Clinical presentation | |||
Cavagnaro et al[104] (2003) | 5M | Bloody diarrhea (> 10 loose stools/d), tenesmus, abdominal tenderness, fever | Oral vancomycin (40 mg/kg per day divided in 6-hourly doses) and IV metronidazole (20 mg/kg per day divided in 8-hourly doses) × 14 d | Resolution of diarrhea within 24 h of steroid initiation |
WBC 19000 cells/mm3, albumin 21 g/L | Resolution of endoscopic changes at 6 wk | |||
Positive C. difficile toxin | IV methyldrnisolone (2 mg/kg per day in two divided doses) on day 14 × 3 d | |||
Pseudomembranous colitis on flexible sigmoidoscopy on day 14 | Prednisone 2 mg/kg per day tapered over one month | |||
Sykes et al[105] (2012) | 54F | Moderate CDI that resolved with 10-d course antibiotics | Oral metronidazole × 10 d with resolution of symptoms (doses not specified) | Decreased stool frequency, normalization of vital signs, reduction in CRP to 132 within 48 h of steroid initiation |
Recurrent diarrhea and abdominal pain 10 d after completion of antibiotics with | Resolution of diarrhea, further reduction in CRP to 15 after 9 d of steroid therapy | |||
left colonic thickening on CT and positive C. difficile toxin | Oral vancomycin and metronidazole upon admission (doses not specified) × 4 d | Resolution of endosocopic changes at 1 mo | ||
Fever, tachycardia on day 4 | Sustained clinical response at 5 mo | |||
with pseudomembranous colitis on flexible sigmoidoscopy | Oral vancomycin 125 mg every 6 h × 9 d | |||
CRP increased from 149 on admission to 236 on day 4 | IV hydrocortisone 100 mg every 6 h × 9 d | |||
Prednisolone 30 mg daily with tapering regimen | ||||
73F | Moderate-severe CDI that resolved with 10-d course antibiotics | Metronidazole 400 mg every 8 h × 10 d with resolution of symptoms | Resolution of diarrhea, normalization of vital signs, reduction in CRP to 7 within 48 h of steroid initiation | |
Recurrent moderate CDI 1 wk after completion of antibiotics that resolved with another 10-d course of antibiotics | Complete clinical response at 14 d with no further relapses | |||
Recurrent CDI 10 d after completion of antibiotics with fever, tachycardia, increased CRP 87 | Oral vancomycin 125 mg every 6 h × 10 d with resolution of symptoms | |||
Slow response to antibiotics with flexible sigmoidoscopy on day 8 with pseudomembranous colitis | ||||
Oral vancomycin 125 mg every 6 h × 8 d with tapering regimen over 14 d | ||||
Prednisolone 30 mg daily × 7 d followed by tapering regimen | ||||
91F | Moderate CDI with persistent diarrhea despite courses of metronidazole and vancomycin | Oral metronidazole 400 mg every 8 h × 10 d without resolution of symptoms | Resolution of diarrhea and normalization of CRP within 72 h of steroid initiation | |
CRP 11 | No further relapses | |||
Flexible sigmoidoscopy with pseudomembranous colitis | Oral vancomycin 125 mg every 6 h for prolonged course without resolution of symptoms | |||
Prednisolone 30 mg daily × 14 d with continued vancomycin tapering regimen over 4 wk |
- Citation: D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/4986.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.4986